As demonstrated by a large number of experiments, the vascular endothelial growth factor (VEGF) is highly expressed in cholangiocarcinoma, and its expression is strongly positive in 41.7% of the patients and weakly positive in 27.8% of the patients [4]. The gene discussed is VEGFA; the disease is cholangiocarcinoma.